noThumbs = true, sDelay = 8000

Stanford Skin Cancer Program

Developing novel immunotherapies for the
treatment of skin cancers

Stanford Skin Cancer Program

Improving diagnostic accuracy through
advanced imaging technologies

Stanford Skin Cancer Program

Leading research in skin cancer prevention,
early detection and treatment

Stanford Skin Cancer Program

Offering total body digital mole mapping
for early detection of melanoma

Stanford Skin Cancer Program

Refer a Patient Make an Appointment Maps & Directions

The Skin Cancer Program at the Stanford Cancer Institute is a leading innovator in the research and treatment of skin cancer, including melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, and cutaneous lymphoma. Through ongoing research and development, as well as the actions of our High Risk/Transplant Dermatology Clinic, our team is improving the diagnosis of skin cancer and advancing the field of treatment options, including:

Innovative surveillance and staging techniques such as total body digital mole mapping for early detection of melanoma and sentinel lymph node (SLN) biopsy with novel imaging modalities to improve accuracy
Immunotherapies that are both FDA-approved and in development, including leading a novel trial of ipilimumab in conjunction with palliative radiation therapy for metastatic melanoma patients
New radiologic tracers for detection of both early and advanced skin diseases
Ongoing clinical trials to test a new class of agents in basal cell carcinoma patients

Our goal is to transform scientific advances at Stanford University in the understanding and causes of skin cancer and discovery of mechanisms of disease into new approaches in diagnosis and treatment for our patients. Learn more about the multidisciplinary, collaborative and expert care offered by the Stanford Skin Cancer Program »